31.10.2013 MediClin AG  DE0006595101

DGAP-News: MediClin AG: Sales above previous year and earnings improvement due to a strong third quarter 2013 - upfront investments in specific capacity reallocations and capacity expansions effecting business development positively.


 
DGAP-News: MediClin AG / Key word(s): Quarter Results MediClin AG: Sales above previous year and earnings improvement due to a strong third quarter 2013 - upfront investments in specific capacity reallocations and capacity expansions effecting business development positively. 31.10.2013 / 16:39 --------------------------------------------------------------------- Sales above previous year and earnings improvement due to a strong third quarter 2013 - upfront investments in specific capacity reallocations and capacity expansions effecting business development positively. Offenburg, October 31, 2013 - In the first nine months of FY 2013 MEDICLIN Aktiengesellschaft (MediClin) has achieved Group sales of EUR 389.7 mill. (9M 2012: EUR 383.8 mill.), which was EUR 5.9 mill. or 1.5 % above the value of the comparison period. In the third quarter 2013 sales amounted to EUR 132.3 mill. matching the high level of the second quarter of 2013 and achieving an increase of EUR 2.6 mill. or 2.0 % against previous year's value. The Group operating result of the first nine months 2013 was EUR 2.2 mill. (9M 2012: EUR 7.4 mill.). In the third quarter of 2013, a Group operating result of EUR 5.8 mill. (Q3 2012: EUR 5.5 mill.) was achieved, which was EUR 0.3 mill. up against previous year's quarter. Thus, the sales decrease of the first quarter 2013 could be more than compensated in the following months. The Group operating result has continuously improved despite high costs, although it is still being below the cumulated value of the previous year. (Q1 2013: EUR -5.9 mill.; Q2 2013: EUR 2.3 mill.; Q3 2013: EUR 5.8 mill.). For the total year of 2013 the Management Board forecasts a slight sales gain in 2013 and expects a Group operating result at the same level as the previous year's result. The specific capacity reallocations and capacity expansions of the last few months will contribute to this in a positive way. Sales increase in the segments and in the business area nursing care In the nine-month comparison and in the quarterly comparison both segments as well as the business area nursing care are reporting sales increases. In the first nine months of 2013 sales of the post-acute segment was EUR 223.2 mill. (+1.1%), sales of the acute segment was EUR 153.8 mill. (+2.0%) and the business area nursing care added sales of EUR 10.1 mill. (+3.4%) to total sales. In the third quarter sales of the post-acute segment increased to EUR 76.1 mill. (+1.2%), sales of the acute segment to EUR 51.8 mill. (+3.2%) and sales of the business area nursing care to EUR 3.4 mill. (+0.9%). Comparing the first nine months of the financial years, segment results were still below the previous year's value, Comparing the quarters, higher sales affected the earnings development positively. The post-acute segment reports for the first nine months of 2013 a segment result of EUR 1.2 mill. (9M 2012: EUR 4.6 mill.) and for the third quarter a result of EUR 3.7 mill. (Q3 2012: EUR 3.3 mill.). In the first nine months of 2013 the acute segment achieved a segment result of EUR 6.0 mill. (9M 2012: EUR 6.7 mill.) and EUR 2.9 mill. in the third quarter of 2013 (Q3 2012: EUR 2.8 mill.). In the first nine months of 2013 about EUR 13.4 mill. (9M 2012: EUR 19.8 mill.) were invested in fixed assets (brutto). Another EUR 12.7 mill. (9M 2012: EUR 12.4 mill.) were spent for service and maintenance. As of September 30, 2013 cash and cash equivalents amounted to EUR 16.7 mill. (31.12.2012: EUR 22.9 mill.); the equity ratio was 48.6 % (31.12.2012: 49.1 %). MediClin employed on average 6,372 employees, calculated on the basis of full-time staff, in the first nine months of 2013, 162 employees more than on average compared with the in same period 2012. The interim report as of September 30, 2013 will be available in German and English from November 12, 2013 under www.mediclin.de. About MediClin AG (Ticker: MED; WKN: 659 510) MediClin AG is a nation-wide clinic operator and large provider of services in the area of Psycho- and Neuro-sciences as well as Orthopaedic. With 34 clinics and 7 nursing care facilities and 11 Medizinische Versorgungszentren (medical care units) in 11 federal states MediClin has a total capacity of approximately 8,100 beds. MediClins' facilities include acute care clinics, i.e., general hospitals, special treatment facilities, specialised hospitals and clinics for post-acute treatment and medical rehabilitation. MediClin has approximately 8,500 employees. MediClin ─ a company of the Asklepios Group. End of Corporate News --------------------------------------------------------------------- 31.10.2013 Dissemination of a Corporate News, transmitted by DGAP - a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------- Language: English Company: MediClin AG Okenstraße 27 77652 Offenburg Germany Phone: +49 (0)781 488-189 Fax: +49 (0)781 488-184 E-mail: [email protected] Internet: www.mediclin.de ISIN: DE0006595101 WKN: 659510 Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin, Düsseldorf, Hamburg, München, Stuttgart End of News DGAP News-Service --------------------------------------------------------------------- 237288 31.10.2013


Die wichtigsten Finanzdaten auf einen Blick
  2017 2018 2019 2020 2021 2022 2023e
Umsatzerlöse1 609,08 645,11 673,09 659,86 673,14 704,70 730,07
EBITDA1,2 27,01 37,35 93,58 77,50 85,22 90,92 98,73
EBITDA-Marge3 4,43 5,79 13,90 11,74 12,66 12,90
EBIT1,4 6,62 15,06 22,41 0,15 11,56 19,52 12,72
EBIT-Marge5 1,09 2,33 3,33 0,02 1,72 2,77 1,74
Jahresüberschuss1 3,96 7,76 9,68 -0,04 1,49 9,72 -10,72
Netto-Marge6 0,65 1,20 1,44 -0,01 0,22 1,38 -1,47
Cashflow1,7 19,34 29,77 69,59 118,69 81,97 34,64 78,00
Ergebnis je Aktie8 0,08 0,16 0,20 -0,19 0,03 0,20 -0,23
Dividende8 0,05 0,05 0,05 0,00 0,00 0,00 0,00
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2023 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: PricewaterhouseCoopers

INVESTOR-INFORMATIONEN
©boersengefluester.de
Mediclin
WKN Kurs in € Einschätzung Börsenwert in Mio. €
659510 2,540 Halten 120,65
KGV 2025e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
9,77 19,17 0,51 19,10
KBV KCV KUV EV/EBITDA
0,62 1,55 0,17 1,42
Dividende '22 in € Dividende '23e in € Div.-Rendite '23e
in %
Hauptversammlung
0,00 0,00 0,00 06.06.2024
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
02.05.2024 31.07.2024 04.11.2024 26.03.2024
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
-1,70% -7,70% -7,30% -25,29%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu MediClin AG  ISIN: DE0006595101 können Sie bei EQS abrufen


Pflegeeinrichtungen , 659510 , MED , XETR:MED